<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02359383</url>
  </required_header>
  <id_info>
    <org_study_id>20133001</org_study_id>
    <nct_id>NCT02359383</nct_id>
  </id_info>
  <brief_title>Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion</brief_title>
  <acronym>FISIOPLEURA</acronym>
  <official_title>Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Granollers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital de Granollers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chest physiotherapy (CP) facilitates the absorption of fluid in the pleural cavity and
      reduces the formation of fibrous adhesions in patients with pleural infection, allowing a
      faster clinical, functional and radiological improve. The aim of the study is to determine if
      the CP associated with conventional medical treatment (CT) improves functional sequelae
      secondary to pleural infectious.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, prospective and randomized trial. Objective: To determine if the Chest
      physiotherapy (CP) associated with conventional medical treatment (CT) improves functional
      sequelae secondary to pleural infectious disease, defined as an increased of 15% in Vital
      Functional Capacity (VFC). Adult patients with diagnosis of pleural infection will be
      included and randomized into two branches: control group - only CT and interventional one -
      CT plus CP.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improve lung function</measure>
    <time_frame>3 months</time_frame>
    <description>To determine if Respiratory Physiotherapy (RP) associated with conventional medical treatment (CT) improves functional sequelae secondary to infectious pleural effusion. All patients will performed spirometric studies at the beginning of the study, at 3 and 6 month.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resolution of pleural effusion</measure>
    <time_frame>3 months</time_frame>
    <description>To analysed if CP allows faster resolution of pleural effusion. A simple thoracic Rx will be performed to assess radiological changes every month till resolution of pleural sequelae.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduce hospital stay</measure>
    <time_frame>3 months</time_frame>
    <description>To assess if CP added to medical therapy in patients with infectious pleural effusion decreased hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Pleural Diseases</condition>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>Chest Physiotherapy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional medical treatment plus Chest Physiotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control grup</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional medical treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chest physiotherapy</intervention_name>
    <description>Depending on the location of the pleural effusion different techniques are performed: 1. Postural control techniques; 2. Secretions drainage techniques; 3. Thoracic expansion techniques; 4. Diaphragmatic mobility techniques.</description>
    <arm_group_label>Chest Physiotherapy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of infectious pleural effusion

          -  Failure to meet any exclusion criteria.

        Exclusion Criteria:

          -  Hemothorax.

          -  Malignant pleural effusion.

          -  Severe comorbidities (end-stage disease, neuromuscular diseases, etc)

          -  Previous ribcage and/or diaphragmatic pathology.

          -  Pregnancy.

          -  Previous respiratory rehabilitation program completed.

          -  Prior pleural pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Inmaculada Castillo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Granollers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Inmaculada Castillo</last_name>
    <phone>+348425000</phone>
    <phone_ext>2675</phone_ext>
    <email>icastillo@fhag.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inmaculada Castillo</name>
      <address>
        <city>Granollers</city>
        <state>Barcelona</state>
        <zip>08401</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inmaculada Castillo</last_name>
      <phone>+348425000</phone>
      <phone_ext>2675</phone_ext>
      <email>icastillo@fhag.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Villena Garrido V, Cases Viedma E, Fernández Villar A, de Pablo Gafas A, Pérez Rodríguez E, Porcel Pérez JM, Rodríguez Panadero F, Ruiz Martínez C, Salvatierra Velázquez A, Valdés Cuadrado L. Recommendations of diagnosis and treatment of pleural effusion. Update. Arch Bronconeumol. 2014 Jun;50(6):235-49. doi: 10.1016/j.arbres.2014.01.016. Epub 2014 Mar 31. Review. English, Spanish.</citation>
    <PMID>24698396</PMID>
  </reference>
  <reference>
    <citation>Villena Garrido V, Ferrer Sancho J, Hernández Blasco L, de Pablo Gafas A, Pérez Rodríguez E, Rodríguez Panadero F, Romero Candeira S, Salvatierra Velázquez A, Valdés Cuadrado L; Area de Tecnicas y Trasplantes. SEPAR. [Diagnosis and treatment of pleural effusion]. Arch Bronconeumol. 2006 Jul;42(7):349-72. Review. Spanish.</citation>
    <PMID>16945266</PMID>
  </reference>
  <reference>
    <citation>Skouras V, Awdankiewicz A, Light RW. What size parapneumonic effusions should be sampled? Thorax. 2010 Jan;65(1):91. doi: 10.1136/thx.2008.112797.</citation>
    <PMID>20029043</PMID>
  </reference>
  <reference>
    <citation>Porcel JM, Light RW. [Parapneumonic pleural effusions and empyema in adults:current practice]. Rev Clin Esp. 2009 Nov;209(10):485-94. Review. Spanish.</citation>
    <PMID>19889319</PMID>
  </reference>
  <reference>
    <citation>Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3(1):75-80. Review.</citation>
    <PMID>16493154</PMID>
  </reference>
  <reference>
    <citation>Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, Sahn S, Weinstein RA, Yusen RD. Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest. 2000 Oct;118(4):1158-71. Review. Erratum in: Chest 2001 Jan;119(1):319.</citation>
    <PMID>11035692</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2015</study_first_submitted>
  <study_first_submitted_qc>February 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2015</study_first_posted>
  <last_update_submitted>September 15, 2015</last_update_submitted>
  <last_update_submitted_qc>September 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Granollers</investigator_affiliation>
    <investigator_full_name>Icastillo</investigator_full_name>
    <investigator_title>Respiratory Therapist</investigator_title>
  </responsible_party>
  <keyword>pleural disease</keyword>
  <keyword>infecTion</keyword>
  <keyword>chest physiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pleural Effusion</mesh_term>
    <mesh_term>Pleural Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

